(Reuters) - ZURICH, April 4 - Swiss healthcare giant Roche Holding AG bolstered its medical testing business on Wednesday by agreeing to buy U.S.-based BioVeris Corp for around $600 million in cash.
The move strengthens Roche's position in diagnostics, where it is already a global market leader, by giving it access to a technology that measures the amount of light given off by molecules under different conditions.
Read more at Reuters.com Mergers News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment